Dupilumab Adverse Events in Nasal Polyp Treatment: Analysis of FDA Adverse Event Reporting System. Swisher AR, Kshirsagar RS, Adappa ND, Liang J, et al. Laryngoscope 2022;132:2307-2313.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Swisher AR, Kshirsagar RS, Adappa ND, Liang J, et al. Dupilumab Adverse Events in Nasal Polyp Treatment: Analysis of FDA Adverse Event Reporting System. Laryngoscope 2022;132:2307-2313.
PMID: 34918342